| Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats M Ploughman, V Windle, CL MacLellan, N White, JJ Doré, D Corbett Stroke 40 (4), 1490-1495, 2009 | 461 | 2009 |
| Accurate molecular classification of kidney cancer subtypes using microRNA signature YM Youssef, NMA White, J Grigull, A Krizova, C Samy, S Mejia-Guerrero, ... European urology 59 (5), 721-730, 2011 | 271 | 2011 |
| The Canadian laboratory initiative on pediatric reference intervals: a CALIPER white paper K Adeli, V Higgins, K Trajcevski, N White-Al Habeeb Critical reviews in clinical laboratory sciences 54 (6), 358-413, 2017 | 248 | 2017 |
| miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation NMA White, TT Bao, J Grigull, YM Youssef, A Girgis, M Diamandis, ... The Journal of urology 186 (3), 1077-1083, 2011 | 232 | 2011 |
| Metastamirs: a stepping stone towards improved cancer management NMA White, E Fatoohi, M Metias, K Jung, C Stephan, GM Yousef Nature reviews Clinical oncology 8 (2), 75-84, 2011 | 215 | 2011 |
| Personalized medicine: marking a new epoch in cancer patient management M Diamandis, NMA White, GM Yousef Molecular Cancer Research 8 (9), 1175-1187, 2010 | 195 | 2010 |
| miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215 NMA White, HWZ Khella, J Grigull, S Adzovic, YM Youssef, RJ Honey, ... British journal of cancer 105 (11), 1741-1749, 2011 | 193 | 2011 |
| Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma H Girgis, O Masui, NMA White, A Scorilas, F Rotondo, A Seivwright, ... Molecular cancer 13, 1-10, 2014 | 181 | 2014 |
| The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma H Faragalla, YM Youssef, A Scorilas, B Khalil, NMA White, ... The Journal of Molecular Diagnostics 14 (4), 385-392, 2012 | 132 | 2012 |
| Endurance exercise facilitates relearning of forelimb motor skill after focal ischemia M Ploughman, Z Attwood, N White, JJE Doré, D Corbett European Journal of Neuroscience 25 (11), 3453-3460, 2007 | 129 | 2007 |
| Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer NMA White, TFF Chow, S Mejia-Guerrero, M Diamandis, Y Rofael, ... British journal of cancer 102 (8), 1244-1253, 2010 | 113 | 2010 |
| Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma NMA White, O Masui, LV DeSouza, O Krakovska-Yutz, S Metias, ... Oncotarget 5 (2), 506, 2014 | 110 | 2014 |
| The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma Z Lichner, A Scorilas, NMA White, AH Girgis, L Rotstein, KC Wiegand, ... The American Journal of Pathology 182 (4), 1163-1170, 2013 | 87 | 2013 |
| KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma NMA White, M Mathews, GM Yousef, A Prizada, C Popadiuk, JJE Doré British journal of cancer 101 (7), 1107-1113, 2009 | 83 | 2009 |
| Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance O Masui, NMA White, LV DeSouza, O Krakovska, A Matta, S Metias, ... Molecular & Cellular Proteomics 12 (1), 132-144, 2013 | 81 | 2013 |
| Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses HWZ Khella, NMA White, H Faragalla, M Gabril, M Boazak, D Dorian, ... Tumor Biology 33, 131-140, 2012 | 72 | 2012 |
| MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer NMA White, GM Yousef BMC medicine 8, 1-4, 2010 | 72 | 2010 |
| Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs NM White, A Bui, S Mejia-Guerrero, J Chao, A Soosaipillai, Y Youssef, ... Walter de Gruyter 391 (4), 411-423, 2010 | 69 | 2010 |
| Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis NMA White, O Masui, D Newsted, A Scorilas, AD Romaschin, ... British journal of cancer 110 (5), 1250-1259, 2014 | 67 | 2014 |
| SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health P Van Caeseele, D Bailey, SE Forgie, TC Dingle, M Krajden, ... Cmaj 192 (34), E973-E979, 2020 | 66 | 2020 |
